Progress Software Corporation (PRGS) Discusses High-Performance Multi-Database Connectivity and WinSQL Features Transcript

Progress Software Corporation ( PRGS) Discusses High-Performance Multi-Database Connectivity and WinSQL Features May 7, 2026 1:00 PM EDT ...
ascopubs.org

LEAP-014: An open-label, randomized, phase 3 study of first-line lenvatinib plus pembrolizumab plus chemotherapy in esophageal squamous cell carcinoma.

INTEGRATE IIb: A randomized phase III open label study of regorafenib + nivolumab versus standard chemotherapy in refractory advanced gastroesophageal cancer (AGOC). This is an ASCO Meeting Abstract ...
ascopubs.org

Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: Final analysis from the phase 3 CheckMate 214 trial.

Combination casdatifan plus cabozantinib expansion cohort of phase 1 ARC-20 study in previously treated patients with clear cell renal cell carcinoma.